Home • Search • Translate
Photos • Biography • Facebook • Twitter

From Wikipedia, the free encyclopedia

Eileen Furlong
FRS MAE
Furlong in 2017
Born
Eileen E.M. Furlong
NationalityIrish
Alma mater University College Dublin (BSc, PhD)
Awards Member of the Academia Europaea (2016)
EMBO Membership (2013)
Scientific career
Fields Enhancers
Chromatin topology
Embryonic development
Single cell genomics
Transcription factors [1]
Institutions European Molecular Biology Laboratory
Stanford University
Thesis Tissue-specific regulation of gene expression by the transcription factors Ying-Yang 1 and nuclear factor 1 (1996)
Doctoral advisorFinian Martin [2]
Website furlonglab.embl.de

Eileen E. M. Furlong FRS MAE is an Irish molecular biologist working in the fields of transcription, chromatin biology, developmental biology and genomics. [3] She is known for her work in understanding how the genome is regulated, in particular to how developmental enhancers function, how they interact within three dimensional chromatin topologies and how they drive cell fate decisions during embryogenesis. [1] [4] [5] She is Head of the Department of Genome Biology at the European Molecular Biology Laboratory (EMBL). Furlong was elected a member of the European Molecular Biology Organization (EMBO) in 2013, [6] the Academia Europaea in 2016 [7] and to EMBO’s research council in 2018. [8]

Education

Eileen Furlong obtained a Bachelor of Science degree at University College Dublin, and a PhD at the Conway institute at UCD, studying transcriptional regulation of immediate early response genes in the lab of Finian Martin. [2]

Career and research

After her PhD, Furlong was a postdoctoral researcher at Stanford University, in Matthew P. Scott's lab, [9] developing genomics tools to functionally dissect developmental programmes during embryogenesis. Furlong started her independent lab at EMBL in 2002, [10] and was appointed head of department [11] in 2009. Her research integrates genomics, genetics and computational biology approaches to functionally dissect the role of non-coding cis-regulatory elements in the regulation of gene expression. [12] [13] In particular, using mesoderm specification into different muscle primordia as a model system. Her group’s research has uncovered a number of properties of enhancers [14] [15] [16] [17] and enhancer- promoter communication, including pre-formed enhancer-promoter ‘ loops’ [18] [19] and the ability of many enhancer’s to function even when larger chromatin topologies are perturbed, [20] [21] [22] in addition to mechanisms that allow enhancers to withstand the effects of genetic variation, including collective transcription factor recruitment, [23] [24] genetic epistasis within enhancers [25] and promoters, [26] and extensive redundancy, [27] which together contribute to canalization in developmental patterning.[ citation needed]

Furlong’s work was credited in the development and application of genomic approaches to understand embryonic development, [28] [29] including the development of Drosophila microarrays, [30] [31] an automatic transgenic embryo sorter, [32] [33] Chromatin immunoprecipitation (ChIP) in embryos, [34] [35] [36] tissue specific [37] [38] [39] and single cell approaches [40] - which combined with genetic manipulations provided insight into developmental programmes during embryogenesis at a genome-wide scale. [41] [42]

Furlong serves on the editorial boards of the scientific journals Developmental Cell, [43] Development, [44] Molecular Systems Biology, [45] Current Opinion in Genetics Development, [46] Current Opinion in Cell Biology, [47] [48] a European Research Council (ERC) panel member [49] [50] and an organiser of the international Conferences From Functional Genomics to Systems Biology, [51] EMBL Transcription and Chromatin [52] meeting, and a keynote speaker at national and international conferences including Intelligent Systems for Molecular Biology (ISMB). [53] [54] [55] [56] [57] [58] [59][ excessive citations]

Awards and honors

Furlong was elected a member of the European Molecular Biology Organization (EMBO) in 2013, [6] and a Member of the Academia Europaea (MAE) in 2016. [7] Furlong was awarded ERC advanced investigator funding CisRegVar 2013-2018 [60] and DeCRypT 2019-2023. [61] She was elected a Fellow of the Royal Society in May 2022. [62]

References

  1. ^ a b Eileen Furlong publications indexed by Google Scholar Edit this at Wikidata
  2. ^ a b Furlong, Eileen E. M. (1996). Tissue-specific regulation of gene expression by the transcription factors Ying-Yang 1 and nuclear factor 1 (PhD thesis). OCLC  605563938. ProQuest  301522152.
  3. ^ Eileen Furlong publications from Europe PubMed Central
  4. ^ "Deciphering the regulatory code". EMBL. 4 November 2009.
  5. ^ Niemitz, Emily (2014). "Synthetic modeling of developmental enhancers". Nature Genetics. 46 (2): 99. doi: 10.1038/ng.2888. ISSN  1546-1718. S2CID  38520086.
  6. ^ a b "Find people in the EMBO Communities". people.embo.org.
  7. ^ a b "Academy of Europe: Furlong Eileen". ae-info.org.
  8. ^ "Council". EMBO. 22 March 2021.
  9. ^ Furlong, Eileen E.M.; Profitt, David; Scott, Matthew P. (2001). "Automated sorting of live transgenic embryos". Nature Biotechnology. 19 (2): 153–156. doi: 10.1038/84422. ISSN  1087-0156. PMID  11175730. S2CID  14228050.
  10. ^ "Furlong Group - Genome regulation and topology during embryonic development - EMBL". embl.de.
  11. ^ "Genome Biology".
  12. ^ Furlong, EEM; Levine, M (28 September 2018). "Developmental enhancers and chromosome topology". Science. 361 (6409): 1341–1345. Bibcode: 2018Sci...361.1341F. doi: 10.1126/science.aau0320. PMC  6986801. PMID  30262496.
  13. ^ Spitz, F; Furlong, EE (September 2012). "Transcription factors: from enhancer binding to developmental control". Nature Reviews. Genetics. 13 (9): 613–26. doi: 10.1038/nrg3207. PMID  22868264. S2CID  205485256.
  14. ^ Zinzen, RP; Girardot, C; Gagneur, J; Braun, M; Furlong, EE (5 November 2009). "Combinatorial binding predicts spatio-temporal cis-regulatory activity". Nature. 462 (7269): 65–70. Bibcode: 2009Natur.462...65Z. doi: 10.1038/nature08531. PMID  19890324. S2CID  4320071.
  15. ^ He, Xin; Sinha, Saurabh (February 2010). "ChIPs and regulatory bits". Nature Biotechnology. 28 (2): 142–143. doi: 10.1038/nbt0210-142. ISSN  1546-1696. PMID  20139950. S2CID  30471127.
  16. ^ Stark, Alexander (1 January 2009). "Learning the transcriptional regulatory code". Molecular Systems Biology. 5 (1): 329. doi: 10.1038/msb.2009.88. ISSN  1744-4292. PMC  2795480. PMID  19920814.
  17. ^ Rister, Jens; Desplan, Claude (2010). "Deciphering the genome's regulatory code: The many languages of DNA". BioEssays. 32 (5): 381–384. doi: 10.1002/bies.200900197. ISSN  1521-1878. PMC  3024831. PMID  20394065.
  18. ^ Ghavi-Helm, Y; Klein, FA; Pakozdi, T; Ciglar, L; Noordermeer, D; Huber, W; Furlong, EE (7 August 2014). "Enhancer loops appear stable during development and are associated with paused polymerase". Nature. 512 (7512): 96–100. Bibcode: 2014Natur.512...96G. doi: 10.1038/nature13417. PMID  25043061. S2CID  4464054.
  19. ^ "Unexpected stability and complexity in transcriptional enhancers' interactions". phys.org.
  20. ^ Ghavi-Helm, Y; Jankowski, A; Meiers, S; Viales, RR; Korbel, JO; Furlong, EEM (August 2019). "Highly rearranged chromosomes reveal uncoupling between genome topology and gene expression". Nature Genetics. 51 (8): 1272–1282. doi: 10.1038/s41588-019-0462-3. PMC  7116017. PMID  31308546.
  21. ^ Finn, Elizabeth H.; Misteli, Tom (August 2019). "A genome disconnect". Nature Genetics. 51 (8): 1205–1206. doi: 10.1038/s41588-019-0476-x. ISSN  1546-1718. PMC  7418859. PMID  31332379.
  22. ^ Koch, Linda (October 2019). "Toppling TAD tenets". Nature Reviews Genetics. 20 (10): 565. doi: 10.1038/s41576-019-0164-9. ISSN  1471-0064. PMID  31367009. S2CID  199056689.
  23. ^ Junion, G; Spivakov, M; Girardot, C; Braun, M; Gustafson, EH; Birney, E; Furlong, EE (3 February 2012). "A transcription factor collective defines cardiac cell fate and reflects lineage history". Cell. 148 (3): 473–86. doi: 10.1016/j.cell.2012.01.030. PMID  22304916. S2CID  7990140.
  24. ^ Khoueiry, P; Girardot, C; Ciglar, L; Peng, PC; Gustafson, EH; Sinha, S; Furlong, EE (9 August 2017). "Uncoupling evolutionary changes in DNA sequence, transcription factor occupancy and enhancer activity". eLife. 6. doi: 10.7554/eLife.28440. PMC  5550276. PMID  28792889.
  25. ^ Cannavò, E; Koelling, N; Harnett, D; Garfield, D; Casale, FP; Ciglar, L; Gustafson, HE; Viales, RR; Marco-Ferreres, R; Degner, JF; Zhao, B; Stegle, O; Birney, E; Furlong, EE (19 January 2017). "Genetic variants regulating expression levels and isoform diversity during embryogenesis". Nature. 541 (7637): 402–406. Bibcode: 2017Natur.541..402C. doi: 10.1038/nature20802. PMID  28024300. S2CID  205252947.
  26. ^ Schor, IE; Degner, JF; Harnett, D; Cannavò, E; Casale, FP; Shim, H; Garfield, DA; Birney, E; Stephens, M; Stegle, O; Furlong, EE (April 2017). "Promoter shape varies across populations and affects promoter evolution and expression noise". Nature Genetics. 49 (4): 550–558. doi: 10.1038/ng.3791. hdl: 11336/65679. PMID  28191888. S2CID  3331476.
  27. ^ Cannavò, E; Khoueiry, P; Garfield, DA; Geeleher, P; Zichner, T; Gustafson, EH; Ciglar, L; Korbel, JO; Furlong, EE (11 January 2016). "Shadow Enhancers Are Pervasive Features of Developmental Regulatory Networks". Current Biology. 26 (1): 38–51. doi: 10.1016/j.cub.2015.11.034. PMC  4712172. PMID  26687625.
  28. ^ McGuire, AL; Gabriel, S; Tishkoff, SA; Wonkam, A; Chakravarti, A; Furlong, EEM; Treutlein, B; Meissner, A; Chang, HY; López-Bigas, N; Segal, E; Kim, JS (October 2020). "The road ahead in genetics and genomics". Nature Reviews. Genetics. 21 (10): 581–596. doi: 10.1038/s41576-020-0272-6. PMC  7444682. PMID  32839576.
  29. ^ Flintoft, Louisa (February 2013). "Predictions across space and time". Nature Reviews Genetics. 14 (2): 78–79. doi: 10.1038/nrg3411. ISSN  1471-0064. PMID  23269464. S2CID  41780530.
  30. ^ Arbeitman, MN; Furlong, EE; Imam, F; Johnson, E; Null, BH; Baker, BS; Krasnow, MA; Scott, MP; Davis, RW; White, KP (2002). "Gene expression during the life cycle of Drosophila melanogaster". Science. 297 (5590): 2270–5. Bibcode: 2002Sci...297.2270A. doi: 10.1126/science.1072152. PMID  12351791. S2CID  15639586.
  31. ^ Science, American Association for the Advancement of (27 September 2002). "This Week in Science: Editor summaries of this week's papers". Science. 297 (5590): 2165. doi: 10.1126/science.2002.297.5590.twis. ISSN  0036-8075. S2CID  239597164.
  32. ^ Furlong, EE; Profitt, D; Scott, MP (February 2001). "Automated sorting of live transgenic embryos". Nature Biotechnology. 19 (2): 153–6. doi: 10.1038/84422. PMID  11175730. S2CID  14228050.
  33. ^ "Biological particle sorter". Google Patents. 21 March 2001.
  34. ^ Sandmann, T; Jensen, LJ; Jakobsen, JS; Karzynski, MM; Eichenlaub, MP; Bork, P; Furlong, EE (June 2006). "A temporal map of transcription factor activity: mef2 directly regulates target genes at all stages of muscle development". Developmental Cell. 10 (6): 797–807. doi: 10.1016/j.devcel.2006.04.009. PMID  16740481.
  35. ^ Sandmann, T; Girardot, C; Brehme, M; Tongprasit, W; Stolc, V; Furlong, EE (15 February 2007). "A core transcriptional network for early mesoderm development in Drosophila melanogaster". Genes & Development. 21 (4): 436–49. doi: 10.1101/gad.1509007. PMC  1804332. PMID  17322403.
  36. ^ Skipper, Magdalena (April 2007). "Chipping away at developmental networks". Nature Reviews Genetics. 8 (4): 249. doi: 10.1038/nrg2077. ISSN  1471-0064. S2CID  38908110.
  37. ^ Bonn, S; Zinzen, RP; Girardot, C; Gustafson, EH; Perez-Gonzalez, A; Delhomme, N; Ghavi-Helm, Y; Wilczyński, B; Riddell, A; Furlong, EE (8 January 2012). "Tissue-specific analysis of chromatin state identifies temporal signatures of enhancer activity during embryonic development". Nature Genetics. 44 (2): 148–56. doi: 10.1038/ng.1064. PMID  22231485. S2CID  143727.
  38. ^ Bonn, S; Zinzen, RP; Perez-Gonzalez, A; Riddell, A; Gavin, AC; Furlong, EE (26 April 2012). "Cell type-specific chromatin immunoprecipitation from multicellular complex samples using BiTS-ChIP". Nature Protocols. 7 (5): 978–94. doi: 10.1038/nprot.2012.049. PMID  22538849. S2CID  20098167.
  39. ^ Reddington, JP; Garfield, DA; Sigalova, OM; Karabacak Calviello, A; Marco-Ferreres, R; Girardot, C; Viales, RR; Degner, JF; Ohler, U; Furlong, EEM (7 December 2020). "Lineage-Resolved Enhancer and Promoter Usage during a Time Course of Embryogenesis". Developmental Cell. 55 (5): 648–664.e9. doi: 10.1016/j.devcel.2020.10.009. PMID  33171098. S2CID  226302320.
  40. ^ Cusanovich, DA; Reddington, JP; Garfield, DA; Daza, RM; Aghamirzaie, D; Marco-Ferreres, R; Pliner, HA; Christiansen, L; Qiu, X; Steemers, FJ; Trapnell, C; Shendure, J; Furlong, EEM (2018). "The cis-regulatory dynamics of embryonic development at single-cell resolution". Nature. 555 (7697): 538–542. Bibcode: 2018Natur.555..538C. doi: 10.1038/nature25981. PMC  5866720. PMID  29539636.
  41. ^ Furlong, EE; Andersen, EC; Null, B; White, KP; Scott, MP (31 August 2001). "Patterns of gene expression during Drosophila mesoderm development". Science. 293 (5535): 1629–33. Bibcode: 2001Sci...293.1629F. doi: 10.1126/science.1062660. PMID  11486054. S2CID  13826608.
  42. ^ Science, American Association for the Advancement of (31 August 2001). "This Week in Science: Research in Science journals". Science. 293 (5535): 1553. doi: 10.1126/science.2001.293.5535.twis. ISSN  0036-8075.
  43. ^ "Editorial Board: Developmental Cell". cell.com.
  44. ^ "Editors and Board | Development". dev.biologists.org.
  45. ^ "Editors & Board | Molecular Systems Biology". embopress.org.
  46. ^ "Current Opinion in Genetics & Development Editorial Board".
  47. ^ "Current Opinion in Cell Biology - Journal - Elsevier".
  48. ^ "Current Opinion in Cell Biology Editorial Board".
  49. ^ "ERC Investigators - EMBL". embl.de.
  50. ^ "Futures: Genome regulation - ERC grantee Eileen Furlong". EMBL. 13 March 2017.
  51. ^ "EMBL Conference - from Functional Genomics to Systems Biology -".
  52. ^ "14th EMBL Conference - Transcription and Chromatin - Virtual - Speakers".
  53. ^ "Evolutionary Systems Biology". Wellcome Connecting Science Courses and Conferences.
  54. ^ "CSH Asia 2020 Conference Systems Biology of Gene Regulation and Genome Editing". cshl.csh-asia.org.
  55. ^ "Flyer Online Symposium Minerva-Gentner Symposium 2020" (PDF).
  56. ^ "Speaker - Cell Symposia: Transcriptional Regulation". cell-symposia.com.
  57. ^ "Eileen Furlong". iscb.org.
  58. ^ "EMBL professor Eileen Furlong: keynote on Genome Regulation". UBC. 4 October 2017.
  59. ^ Pathology, Research Institute of Molecular. "Eileen Furlong to give Max Birnstiel Lecture". The Research Institute of Molecular Pathology.
  60. ^ "ERC grant CisRegVar".
  61. ^ "ERC grant DeCRypT".
  62. ^ "Outstanding scientists elected as Fellows and Foreign Members of the Royal Society". Royal Society. 10 May 2022. Retrieved 11 May 2022.
Retrieved from " https://en.wikipedia.org/?title=Eileen_Furlong&oldid=1221328361"
From Wikipedia, the free encyclopedia

Eileen Furlong
FRS MAE
Furlong in 2017
Born
Eileen E.M. Furlong
NationalityIrish
Alma mater University College Dublin (BSc, PhD)
Awards Member of the Academia Europaea (2016)
EMBO Membership (2013)
Scientific career
Fields Enhancers
Chromatin topology
Embryonic development
Single cell genomics
Transcription factors [1]
Institutions European Molecular Biology Laboratory
Stanford University
Thesis Tissue-specific regulation of gene expression by the transcription factors Ying-Yang 1 and nuclear factor 1 (1996)
Doctoral advisorFinian Martin [2]
Website furlonglab.embl.de

Eileen E. M. Furlong FRS MAE is an Irish molecular biologist working in the fields of transcription, chromatin biology, developmental biology and genomics. [3] She is known for her work in understanding how the genome is regulated, in particular to how developmental enhancers function, how they interact within three dimensional chromatin topologies and how they drive cell fate decisions during embryogenesis. [1] [4] [5] She is Head of the Department of Genome Biology at the European Molecular Biology Laboratory (EMBL). Furlong was elected a member of the European Molecular Biology Organization (EMBO) in 2013, [6] the Academia Europaea in 2016 [7] and to EMBO’s research council in 2018. [8]

Education

Eileen Furlong obtained a Bachelor of Science degree at University College Dublin, and a PhD at the Conway institute at UCD, studying transcriptional regulation of immediate early response genes in the lab of Finian Martin. [2]

Career and research

After her PhD, Furlong was a postdoctoral researcher at Stanford University, in Matthew P. Scott's lab, [9] developing genomics tools to functionally dissect developmental programmes during embryogenesis. Furlong started her independent lab at EMBL in 2002, [10] and was appointed head of department [11] in 2009. Her research integrates genomics, genetics and computational biology approaches to functionally dissect the role of non-coding cis-regulatory elements in the regulation of gene expression. [12] [13] In particular, using mesoderm specification into different muscle primordia as a model system. Her group’s research has uncovered a number of properties of enhancers [14] [15] [16] [17] and enhancer- promoter communication, including pre-formed enhancer-promoter ‘ loops’ [18] [19] and the ability of many enhancer’s to function even when larger chromatin topologies are perturbed, [20] [21] [22] in addition to mechanisms that allow enhancers to withstand the effects of genetic variation, including collective transcription factor recruitment, [23] [24] genetic epistasis within enhancers [25] and promoters, [26] and extensive redundancy, [27] which together contribute to canalization in developmental patterning.[ citation needed]

Furlong’s work was credited in the development and application of genomic approaches to understand embryonic development, [28] [29] including the development of Drosophila microarrays, [30] [31] an automatic transgenic embryo sorter, [32] [33] Chromatin immunoprecipitation (ChIP) in embryos, [34] [35] [36] tissue specific [37] [38] [39] and single cell approaches [40] - which combined with genetic manipulations provided insight into developmental programmes during embryogenesis at a genome-wide scale. [41] [42]

Furlong serves on the editorial boards of the scientific journals Developmental Cell, [43] Development, [44] Molecular Systems Biology, [45] Current Opinion in Genetics Development, [46] Current Opinion in Cell Biology, [47] [48] a European Research Council (ERC) panel member [49] [50] and an organiser of the international Conferences From Functional Genomics to Systems Biology, [51] EMBL Transcription and Chromatin [52] meeting, and a keynote speaker at national and international conferences including Intelligent Systems for Molecular Biology (ISMB). [53] [54] [55] [56] [57] [58] [59][ excessive citations]

Awards and honors

Furlong was elected a member of the European Molecular Biology Organization (EMBO) in 2013, [6] and a Member of the Academia Europaea (MAE) in 2016. [7] Furlong was awarded ERC advanced investigator funding CisRegVar 2013-2018 [60] and DeCRypT 2019-2023. [61] She was elected a Fellow of the Royal Society in May 2022. [62]

References

  1. ^ a b Eileen Furlong publications indexed by Google Scholar Edit this at Wikidata
  2. ^ a b Furlong, Eileen E. M. (1996). Tissue-specific regulation of gene expression by the transcription factors Ying-Yang 1 and nuclear factor 1 (PhD thesis). OCLC  605563938. ProQuest  301522152.
  3. ^ Eileen Furlong publications from Europe PubMed Central
  4. ^ "Deciphering the regulatory code". EMBL. 4 November 2009.
  5. ^ Niemitz, Emily (2014). "Synthetic modeling of developmental enhancers". Nature Genetics. 46 (2): 99. doi: 10.1038/ng.2888. ISSN  1546-1718. S2CID  38520086.
  6. ^ a b "Find people in the EMBO Communities". people.embo.org.
  7. ^ a b "Academy of Europe: Furlong Eileen". ae-info.org.
  8. ^ "Council". EMBO. 22 March 2021.
  9. ^ Furlong, Eileen E.M.; Profitt, David; Scott, Matthew P. (2001). "Automated sorting of live transgenic embryos". Nature Biotechnology. 19 (2): 153–156. doi: 10.1038/84422. ISSN  1087-0156. PMID  11175730. S2CID  14228050.
  10. ^ "Furlong Group - Genome regulation and topology during embryonic development - EMBL". embl.de.
  11. ^ "Genome Biology".
  12. ^ Furlong, EEM; Levine, M (28 September 2018). "Developmental enhancers and chromosome topology". Science. 361 (6409): 1341–1345. Bibcode: 2018Sci...361.1341F. doi: 10.1126/science.aau0320. PMC  6986801. PMID  30262496.
  13. ^ Spitz, F; Furlong, EE (September 2012). "Transcription factors: from enhancer binding to developmental control". Nature Reviews. Genetics. 13 (9): 613–26. doi: 10.1038/nrg3207. PMID  22868264. S2CID  205485256.
  14. ^ Zinzen, RP; Girardot, C; Gagneur, J; Braun, M; Furlong, EE (5 November 2009). "Combinatorial binding predicts spatio-temporal cis-regulatory activity". Nature. 462 (7269): 65–70. Bibcode: 2009Natur.462...65Z. doi: 10.1038/nature08531. PMID  19890324. S2CID  4320071.
  15. ^ He, Xin; Sinha, Saurabh (February 2010). "ChIPs and regulatory bits". Nature Biotechnology. 28 (2): 142–143. doi: 10.1038/nbt0210-142. ISSN  1546-1696. PMID  20139950. S2CID  30471127.
  16. ^ Stark, Alexander (1 January 2009). "Learning the transcriptional regulatory code". Molecular Systems Biology. 5 (1): 329. doi: 10.1038/msb.2009.88. ISSN  1744-4292. PMC  2795480. PMID  19920814.
  17. ^ Rister, Jens; Desplan, Claude (2010). "Deciphering the genome's regulatory code: The many languages of DNA". BioEssays. 32 (5): 381–384. doi: 10.1002/bies.200900197. ISSN  1521-1878. PMC  3024831. PMID  20394065.
  18. ^ Ghavi-Helm, Y; Klein, FA; Pakozdi, T; Ciglar, L; Noordermeer, D; Huber, W; Furlong, EE (7 August 2014). "Enhancer loops appear stable during development and are associated with paused polymerase". Nature. 512 (7512): 96–100. Bibcode: 2014Natur.512...96G. doi: 10.1038/nature13417. PMID  25043061. S2CID  4464054.
  19. ^ "Unexpected stability and complexity in transcriptional enhancers' interactions". phys.org.
  20. ^ Ghavi-Helm, Y; Jankowski, A; Meiers, S; Viales, RR; Korbel, JO; Furlong, EEM (August 2019). "Highly rearranged chromosomes reveal uncoupling between genome topology and gene expression". Nature Genetics. 51 (8): 1272–1282. doi: 10.1038/s41588-019-0462-3. PMC  7116017. PMID  31308546.
  21. ^ Finn, Elizabeth H.; Misteli, Tom (August 2019). "A genome disconnect". Nature Genetics. 51 (8): 1205–1206. doi: 10.1038/s41588-019-0476-x. ISSN  1546-1718. PMC  7418859. PMID  31332379.
  22. ^ Koch, Linda (October 2019). "Toppling TAD tenets". Nature Reviews Genetics. 20 (10): 565. doi: 10.1038/s41576-019-0164-9. ISSN  1471-0064. PMID  31367009. S2CID  199056689.
  23. ^ Junion, G; Spivakov, M; Girardot, C; Braun, M; Gustafson, EH; Birney, E; Furlong, EE (3 February 2012). "A transcription factor collective defines cardiac cell fate and reflects lineage history". Cell. 148 (3): 473–86. doi: 10.1016/j.cell.2012.01.030. PMID  22304916. S2CID  7990140.
  24. ^ Khoueiry, P; Girardot, C; Ciglar, L; Peng, PC; Gustafson, EH; Sinha, S; Furlong, EE (9 August 2017). "Uncoupling evolutionary changes in DNA sequence, transcription factor occupancy and enhancer activity". eLife. 6. doi: 10.7554/eLife.28440. PMC  5550276. PMID  28792889.
  25. ^ Cannavò, E; Koelling, N; Harnett, D; Garfield, D; Casale, FP; Ciglar, L; Gustafson, HE; Viales, RR; Marco-Ferreres, R; Degner, JF; Zhao, B; Stegle, O; Birney, E; Furlong, EE (19 January 2017). "Genetic variants regulating expression levels and isoform diversity during embryogenesis". Nature. 541 (7637): 402–406. Bibcode: 2017Natur.541..402C. doi: 10.1038/nature20802. PMID  28024300. S2CID  205252947.
  26. ^ Schor, IE; Degner, JF; Harnett, D; Cannavò, E; Casale, FP; Shim, H; Garfield, DA; Birney, E; Stephens, M; Stegle, O; Furlong, EE (April 2017). "Promoter shape varies across populations and affects promoter evolution and expression noise". Nature Genetics. 49 (4): 550–558. doi: 10.1038/ng.3791. hdl: 11336/65679. PMID  28191888. S2CID  3331476.
  27. ^ Cannavò, E; Khoueiry, P; Garfield, DA; Geeleher, P; Zichner, T; Gustafson, EH; Ciglar, L; Korbel, JO; Furlong, EE (11 January 2016). "Shadow Enhancers Are Pervasive Features of Developmental Regulatory Networks". Current Biology. 26 (1): 38–51. doi: 10.1016/j.cub.2015.11.034. PMC  4712172. PMID  26687625.
  28. ^ McGuire, AL; Gabriel, S; Tishkoff, SA; Wonkam, A; Chakravarti, A; Furlong, EEM; Treutlein, B; Meissner, A; Chang, HY; López-Bigas, N; Segal, E; Kim, JS (October 2020). "The road ahead in genetics and genomics". Nature Reviews. Genetics. 21 (10): 581–596. doi: 10.1038/s41576-020-0272-6. PMC  7444682. PMID  32839576.
  29. ^ Flintoft, Louisa (February 2013). "Predictions across space and time". Nature Reviews Genetics. 14 (2): 78–79. doi: 10.1038/nrg3411. ISSN  1471-0064. PMID  23269464. S2CID  41780530.
  30. ^ Arbeitman, MN; Furlong, EE; Imam, F; Johnson, E; Null, BH; Baker, BS; Krasnow, MA; Scott, MP; Davis, RW; White, KP (2002). "Gene expression during the life cycle of Drosophila melanogaster". Science. 297 (5590): 2270–5. Bibcode: 2002Sci...297.2270A. doi: 10.1126/science.1072152. PMID  12351791. S2CID  15639586.
  31. ^ Science, American Association for the Advancement of (27 September 2002). "This Week in Science: Editor summaries of this week's papers". Science. 297 (5590): 2165. doi: 10.1126/science.2002.297.5590.twis. ISSN  0036-8075. S2CID  239597164.
  32. ^ Furlong, EE; Profitt, D; Scott, MP (February 2001). "Automated sorting of live transgenic embryos". Nature Biotechnology. 19 (2): 153–6. doi: 10.1038/84422. PMID  11175730. S2CID  14228050.
  33. ^ "Biological particle sorter". Google Patents. 21 March 2001.
  34. ^ Sandmann, T; Jensen, LJ; Jakobsen, JS; Karzynski, MM; Eichenlaub, MP; Bork, P; Furlong, EE (June 2006). "A temporal map of transcription factor activity: mef2 directly regulates target genes at all stages of muscle development". Developmental Cell. 10 (6): 797–807. doi: 10.1016/j.devcel.2006.04.009. PMID  16740481.
  35. ^ Sandmann, T; Girardot, C; Brehme, M; Tongprasit, W; Stolc, V; Furlong, EE (15 February 2007). "A core transcriptional network for early mesoderm development in Drosophila melanogaster". Genes & Development. 21 (4): 436–49. doi: 10.1101/gad.1509007. PMC  1804332. PMID  17322403.
  36. ^ Skipper, Magdalena (April 2007). "Chipping away at developmental networks". Nature Reviews Genetics. 8 (4): 249. doi: 10.1038/nrg2077. ISSN  1471-0064. S2CID  38908110.
  37. ^ Bonn, S; Zinzen, RP; Girardot, C; Gustafson, EH; Perez-Gonzalez, A; Delhomme, N; Ghavi-Helm, Y; Wilczyński, B; Riddell, A; Furlong, EE (8 January 2012). "Tissue-specific analysis of chromatin state identifies temporal signatures of enhancer activity during embryonic development". Nature Genetics. 44 (2): 148–56. doi: 10.1038/ng.1064. PMID  22231485. S2CID  143727.
  38. ^ Bonn, S; Zinzen, RP; Perez-Gonzalez, A; Riddell, A; Gavin, AC; Furlong, EE (26 April 2012). "Cell type-specific chromatin immunoprecipitation from multicellular complex samples using BiTS-ChIP". Nature Protocols. 7 (5): 978–94. doi: 10.1038/nprot.2012.049. PMID  22538849. S2CID  20098167.
  39. ^ Reddington, JP; Garfield, DA; Sigalova, OM; Karabacak Calviello, A; Marco-Ferreres, R; Girardot, C; Viales, RR; Degner, JF; Ohler, U; Furlong, EEM (7 December 2020). "Lineage-Resolved Enhancer and Promoter Usage during a Time Course of Embryogenesis". Developmental Cell. 55 (5): 648–664.e9. doi: 10.1016/j.devcel.2020.10.009. PMID  33171098. S2CID  226302320.
  40. ^ Cusanovich, DA; Reddington, JP; Garfield, DA; Daza, RM; Aghamirzaie, D; Marco-Ferreres, R; Pliner, HA; Christiansen, L; Qiu, X; Steemers, FJ; Trapnell, C; Shendure, J; Furlong, EEM (2018). "The cis-regulatory dynamics of embryonic development at single-cell resolution". Nature. 555 (7697): 538–542. Bibcode: 2018Natur.555..538C. doi: 10.1038/nature25981. PMC  5866720. PMID  29539636.
  41. ^ Furlong, EE; Andersen, EC; Null, B; White, KP; Scott, MP (31 August 2001). "Patterns of gene expression during Drosophila mesoderm development". Science. 293 (5535): 1629–33. Bibcode: 2001Sci...293.1629F. doi: 10.1126/science.1062660. PMID  11486054. S2CID  13826608.
  42. ^ Science, American Association for the Advancement of (31 August 2001). "This Week in Science: Research in Science journals". Science. 293 (5535): 1553. doi: 10.1126/science.2001.293.5535.twis. ISSN  0036-8075.
  43. ^ "Editorial Board: Developmental Cell". cell.com.
  44. ^ "Editors and Board | Development". dev.biologists.org.
  45. ^ "Editors & Board | Molecular Systems Biology". embopress.org.
  46. ^ "Current Opinion in Genetics & Development Editorial Board".
  47. ^ "Current Opinion in Cell Biology - Journal - Elsevier".
  48. ^ "Current Opinion in Cell Biology Editorial Board".
  49. ^ "ERC Investigators - EMBL". embl.de.
  50. ^ "Futures: Genome regulation - ERC grantee Eileen Furlong". EMBL. 13 March 2017.
  51. ^ "EMBL Conference - from Functional Genomics to Systems Biology -".
  52. ^ "14th EMBL Conference - Transcription and Chromatin - Virtual - Speakers".
  53. ^ "Evolutionary Systems Biology". Wellcome Connecting Science Courses and Conferences.
  54. ^ "CSH Asia 2020 Conference Systems Biology of Gene Regulation and Genome Editing". cshl.csh-asia.org.
  55. ^ "Flyer Online Symposium Minerva-Gentner Symposium 2020" (PDF).
  56. ^ "Speaker - Cell Symposia: Transcriptional Regulation". cell-symposia.com.
  57. ^ "Eileen Furlong". iscb.org.
  58. ^ "EMBL professor Eileen Furlong: keynote on Genome Regulation". UBC. 4 October 2017.
  59. ^ Pathology, Research Institute of Molecular. "Eileen Furlong to give Max Birnstiel Lecture". The Research Institute of Molecular Pathology.
  60. ^ "ERC grant CisRegVar".
  61. ^ "ERC grant DeCRypT".
  62. ^ "Outstanding scientists elected as Fellows and Foreign Members of the Royal Society". Royal Society. 10 May 2022. Retrieved 11 May 2022.
Retrieved from " https://en.wikipedia.org/?title=Eileen_Furlong&oldid=1221328361"

Videos

Youtube | Vimeo | Bing

Websites

Google | Yahoo | Bing

Encyclopedia

Google | Yahoo | Bing

Facebook




Top Of Page

Home • Search • Translate

© CSE